The following is a summary of “Changes in use of migraine medications, healthcare resource utilization, and associated direct costs over 12 Months following initiation of Erenumab: A US retrospective ...

Erenumab effectively induces Medication Overuse Headache remission in chronic migraine patients. Monthly 140 mg injections ...

Monthly use of erenumab injections (140 mg) is safe and effective in achieving medication overuse headache (MOH) remission in ...

Subcutaneous ocrelizumab and hyaluronidase (Ocrevus Zunovo) was approved for relapsing and progressive multiple sclerosis, ...

In this study, monthly, 140 mg erenumab injections safely and effectively achieved medication overuse headaches remission in patients ...

In this study, monthly, 140 mg erenumab injections safely and effectively achieved medication overuse headaches remission in patients with nonopioid chronic migraine and medication overuse headaches ...

Nymalize is indicated for use in adult patients with subarachnoid haemorrhage from ruptured intracranial berry aneurysms. Credit: Radiological imaging/Shutterstock. Azurity Pharmaceuticals’ Nymalize ...

Focus on balanced diets for all demographics Addressing challenges like malnutrition, obesity, and food insecurity Government and community-based interventions for better nutrition Each year ...

Since Sunday, Tropical Storm Enteng (international name: Yagi) has brought rains and caused heavy flooding in Metro Manila and its neighboring cities, with Signal No. 2 raised in nine areas in Luzon.